Literature DB >> 1289358

In-vivo activity of streptomycin and clofazimine against established infections of Mycobacterium avium complex in beige mice.

P R Gangadharam1, K Parikh.   

Abstract

Beige mice were challenged with 10(6)-10(7) cfu of Mycobacterium avium intracellulare strain 101 and 22 days later treated with streptomycin 150 mg/kg/day alone, clofazimine 20 mg/kg/day alone, streptomycin 150 mg/kg/day plus clofazimine 20 mg/kg/day, or no antimicrobial agent (untreated controls). Both single-drug therapies partially reduced the cfu counts in spleen, liver and lungs compared with the controls however the combination was significantly more effective and completely eliminated the pathogen from the spleen and lungs of some animals after eight weeks treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1289358     DOI: 10.1093/jac/30.6.833

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

1.  Evidence for a reduced chemokine response in the lungs of beige mice infected with Mycobacterium avium.

Authors:  M Florido; R Appelberg; I M Orme; A M Cooper
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

Review 2.  Beige mouse model for Mycobacterium avium complex disease.

Authors:  P R Gangadharam
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

Review 3.  Animal and cell-culture models for the study of mycobacterial infections and treatment.

Authors:  I M Orme; A D Roberts; S K Furney; P S Skinner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

4.  Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes.

Authors:  P R Gangadharam; D R Ashtekar; D L Flasher; N Düzgüneş
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

Review 5.  Activity of Riminophenazines against Mycobacterium tuberculosis: A Review of Studies that Might be Contenders for Use as Antituberculosis Agents.

Authors:  Mpelegeng Victoria Bvumbi
Journal:  ChemMedChem       Date:  2020-10-15       Impact factor: 3.540

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.